Description: Health-care giant Johnson & Johnson is splitting off its consumer division, following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.
Source: BNNBloomberg.com – video report
Date: Nov 12, 2021
Questions for discussion:
- What is motivating the firm to split itself into two companies at this time?
- Do you think this is a good strategic decision for stockholders?
- How do you think investors should deal with the choices – hold both companies, buy one, or sell?